There may be up to a tenfold difference in risk for infants who are currently treated identically under clinical guidelines, ...

As previously announced, this year’s Grammy telecast will go forward live on CBS “with a renewed sense of purpose.” On Feb. 2 ...

You’re going to heart these unbeatable deals from J.Crew’s extra 50% off sale—with red hot styles starting at $17. You have just 24 hours to score this rare 80% discount on Dr. Denese's ...

The Vancouver Canucks are looking to rebound from a tough loss by topping the Los Angeles Kings at Rogers Arena on Thursday, January 16. Vancouver star Quinn Hughes headlines my top Kings vs.

Retail sales grow by 0.4% month-on-month in December, slower than expected By Investing.com - Jan 16, 2025 7 Investing.com - US retail sales increased at a slower-than-anticipated month-on-month ...

This article will look at the company’s current market position and make a META stock price prediction for the years ... of META shares despite recent sales. On the institutional side, the ...

(Reuters) -Eli Lilly's stock tumbled 8% on Tuesday after it forecast fourth-quarter sales of weight-loss drug Zepbound below Wall Street estimates, marking the second time sales have disappointed ...

Guidance for diabetes drug Mounjaro is $3.5 billion, while weight loss drug Zepbound is expected to bring in $1.9 billion for the quarter. In the latest weekly prescription tracking from JPMorgan ...

FILE PHOTO: An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023. REUTERS/Brendan McDermid/File Photo · REUTERS / Reuters JPMorgan analyst ...

Tuesday, Five Below (NASDAQ:FIVE) shares, trading at $99.90 and down nearly 5% year-to-date, maintained their Sector Weight rating by KeyBanc, as the company disclosed its updated ...